Sarcopenia as a risk factor of severe laboratory adverse events in breast cancer patients receiving perioperative epirubicin plus cyclophosphamide therapy.
Autor: | Ueno, Ayako1 (AUTHOR) ayako.u.222@outlook.jp, Yamaguchi, Kazushige1 (AUTHOR), Sudo, Moe1 (AUTHOR), Imai, Shiro1,2 (AUTHOR) |
---|---|
Zdroj: | Supportive Care in Cancer. Sep2020, Vol. 28 Issue 9, p4249-4254. 6p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |